Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
To cover taxesNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025 and Mar 2026.
- Largest single sale: $1.2M (17,900 shares) of Halozyme Therapeutics, Inc. on Mar 9, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Halozyme Therapeutics, Inc. (HALO) | SVP, Chief Operating Officer | Oct 6, 2025 | Mar 10, 2026 |
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Mar 10, 2026, Halozyme Therapeutics, Inc.: sold 8,857 shares for $599K, no plan disclosed; 1,546 shares vested or acquired by exercising options. 1 filing: 1
- Mar 9, 2026, Halozyme Therapeutics, Inc.: sold 20,000 shares for $1.4M, no plan disclosed; 20,000 shares vested or acquired by exercising options. 1 filing: 1
- Feb 20, 2026, Halozyme Therapeutics, Inc.: 2,666 shares vested; 1,037 shares withheld by the company for taxes. 1 filing: 1
- Nov 1, 2025, Halozyme Therapeutics, Inc.: sold 4,263 shares for $278K, to cover taxes; 9,326 shares vested. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.